These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25850829)

  • 1. Novel inflammatory biomarkers in primary hyperparathyroidism.
    Christensen MH; Fenne IS; Nordbø Y; Varhaug JE; Nygård KO; Lien EA; Mellgren G
    Eur J Endocrinol; 2015 Jul; 173(1):9-17. PubMed ID: 25850829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
    Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.
    Christensen MH; Pedersen EK; Nordbø Y; Varhaug JE; Midttun Ø; Ueland PM; Nygård OK; Mellgren G; Lien EA
    J Intern Med; 2012 Dec; 272(6):583-91. PubMed ID: 22757621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study.
    Weber T; Eberle J; Messelhäuser U; Schiffmann L; Nies C; Schabram J; Zielke A; Holzer K; Rottler E; Henne-Bruns D; Keller M; von Wietersheim J
    JAMA Surg; 2013 Feb; 148(2):109-15. PubMed ID: 23560281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
    Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study.
    Agarwal G; Nanda G; Kapoor A; Singh KR; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Syal SK
    Surgery; 2013 Dec; 154(6):1394-403; discussion 1403-4. PubMed ID: 24045156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial.
    Heck A; Pretorius M; Lundstam K; Godang K; Hellström M; Ueland T; Bollerslev J
    Eur J Endocrinol; 2024 Aug; 191(3):354-360. PubMed ID: 39189547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism.
    Curione M; Amato S; Di Bona S; Petramala L; Cotesta D; Letizia C
    Int J Cardiol; 2010 May; 141(2):201-2. PubMed ID: 19346020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
    Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism.
    Almqvist EG; Bondeson AG; Bondeson L; Svensson J
    Scand J Clin Lab Invest; 2011 Apr; 71(2):139-44. PubMed ID: 21166606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
    Verheyen N; Meinitzer A; Grübler MR; Ablasser K; Kolesnik E; Fahrleitner-Pammer A; Belyavskiy E; Trummer C; Schwetz V; Pieske-Kraigher E; Voelkl J; Alesutan I; Catena C; Sechi LA; Brussee H; Lewinski DV; März W; Pieske B; Pilz S; Tomaschitz A
    Clin Chem Lab Med; 2017 Jun; 55(7):1034-1042. PubMed ID: 28432842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
    Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
    Osto E; Fallo F; Pelizzo MR; Maddalozzo A; Sorgato N; Corbetti F; Montisci R; Famoso G; Bellu R; Lüscher TF; Iliceto S; Tona F
    Circulation; 2012 Aug; 126(9):1031-9. PubMed ID: 22821942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.
    Feldstein CA; Akopian M; Pietrobelli D; Olivieri A; Garrido D
    Clin Exp Hypertens; 2010 May; 32(3):154-8. PubMed ID: 20504122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism.
    Hagström E; Lundgren E; Mallmin H; Rastad J; Hellman P
    J Intern Med; 2006 Feb; 259(2):191-8. PubMed ID: 16420548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.